Nephron Pharmaceuticals Corp.

FDA Regulatory Profile

Summary

Total Recalls
10 (3 Class I)
510(k) Clearances
2
Inspections
2
Compliance Actions
0

Recent Recalls

NumberClassProductDate
Z-2053-2016Class IISodium Chloride Inhalation Solution, USP 3%, 60 x 4 mL Sterile Unit-Dose Vials per carton, Rx Only, November 16, 2015
Z-2054-2016Class IISodium Chloride Inhalation Solution, USP 7%, 60 x 4 mL Sterile Unit-Dose Vials, Rx Only, NDC 0487-90November 16, 2015
D-0010-2016Class IIIpratropium Bromide 0.5 mg and Albuterol Sulfate 3 mg Inhalation Solution, packaged in 30x3 mL SteriAugust 21, 2015
D-0388-2016Class IIAsthmanefrin Racepinephrine Inhalation Solution Bronchodilator, Starter Kit (Racepinephrine 11.25 mgAugust 21, 2015
D-0389-2016Class IIAsthmanefrin Racepinephrine Inhalation Solution Bronchodilator Refills (Racepinephrine USP 11.25 mgAugust 21, 2015
D-66462-001Class IIAlbuterol Sulfate Inhalation Solution, 0.083% 2.5 mg/3 mL for Oral Inhalation Only, Rx Only, 25 x 3October 2, 2013
Z-1373-2013Class IEZ Breathe Medication Cup. For the delivery of liquid medications for respiratory usage.April 30, 2013
Z-1372-2013Class IAsthmaNefrin Starter Kit contains ten (10) AsthmaNefrin vials and one (1) EZ Breathe Atomizer. FoApril 30, 2013
Z-1371-2013Class IEZ Breathe Atomizer Model # EZ-100. For the delivery of liquid medications for respiratory usageApril 30, 2013
D-1446-2012Class IIAlbuterol Sulfate Inhalation Solution, 0.083%, 2.5 mg/3 mL Sterile Unit-Dose Vials, 60-count (60 x 3June 22, 2011

Recent 510(k) Clearances

K-NumberDeviceDate
K113033SODIUM CHLORDE INHALATION SOLUTION, 0.9% USP-3MLJune 19, 2012
K120051SODIUM CHLORIDE INHALATION SOLUTION, 3%, 7%, AND 10%, USP-4MLApril 20, 2012